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Abstract
Best-worst scaling (BWS), also known as maximum-difference scaling, is a multiattribute approach to measuring
preferences. BWS aims at the analysis of preferences regarding a set of attributes, their levels or alternatives. It is a
stated-preference method based on the assumption that respondents are capable of making judgments regarding
the best and the worst (or the most and least important, respectively) out of three or more elements of a choice-
set. As is true of discrete choice experiments (DCE) generally, BWS avoids the known weaknesses of rating and
ranking scales while holding the promise of generating additional information by making respondents choose
twice, namely the best as well as the worst criteria. A systematic literature review found 53 BWS applications in
health and healthcare. This article expounds possibilities of application, the underlying theoretical concepts and the
implementation of BWS in its three variants: ‘object case’, ‘profile case’, ‘multiprofile case’. This paper contains a
survey of BWS methods and revolves around study design, experimental design, and data analysis. Moreover the
article discusses the strengths and weaknesses of the three types of BWS distinguished and offered an outlook. A
companion paper focuses on special issues of theory and statistical inference confronting BWS in preference
measurement.
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Background: preferences in healthcare decision
making
The primary responsibility of healthcare decision makers
is to determine the optimal allocation of scarce money,
time, and technological resources, given available infor-
mation on outcomes. Both regulatory and clinical
healthcare decisions indirectly or directly affect the wel-
fare of healthcare recipients. However, decision makers
often lack information about how the criteria they use
should be weighted from the point of view of taxpayers,
insurers, and patients. For example, little is known about
patients’ willingness to accept trade-offs among life-
years gained, restrictions on activities of daily living, and
the risk of side effects. To the extent that healthcare de-
cision makers lack information on the preferences of
those affected, resource-allocation decisions will fail to
achieve optimal outcomes.
When searching for optimal solutions, decision makers
therefore inevitably must evaluate trade-offs, which call
for multiattribute valuation methods. In this task,
discrete choice experiment (DCE) methods have proven
to be particularly useful [1–5]. More recently, some re-
searchers have proposed using best-worst scaling (BWS)
methods. BWS is a variant of DCEs that seeks to obtain
extra information by asking survey respondents to sim-
ultaneously identify the best and worst items in each set
of scenarios (attributes, levels or alternatives).
This paper is structured as follows. In Literature re-
view the underlying systematic review of published BWS
studies in health and healthcare is described. BWS - sur-
vey of methods contains a survey of BWS methods,
while Conducting a BWS experiment revolves around
study design, experimental design, and data analysis.
Overview of recent BWS applications discusses the
strengths and weaknesses of the three types of BWS
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distinguished. An overview of applications of BWS is
presented in Discussion: strengths and weaknesses in ap-
plication. Conclusions and an outlook are offered in
Conclusions and outlook. A companion paper (Mühlba-
cher et al. [6]) focuses on special issues of theory and
statistical inference confronting BWS in preference
measurement.
Literature review
A systematic review was conducted, limited to English
and German language publications in the databases
‘pubmed’ and ‘springerlink’. Overall 53 BWS applications
were published in the last 10 years until September
2015. The following search terms were used for the re-
view: ‘Best-Worst Scaling’, ‘Best-Worst Scaling AND
Health*’, ‘Best Worst Scaling’, ‘Best Worst Scaling AND
Health*’, ‘MaxDiff Scaling’, ‘Maximum Difference Scaling’.
Data on authors, title, date, type of elicitation format,
study objective, and sample size were extracted.
BWS - survey of methods
Microeconomic foundations
BWS as a variant of DCE starts from the basic assump-
tion of Thurstone that individuals maximize utility, with
some determinants of utility unobservable for the exper-
imenters [7]. Hence, utility can be decomposed into a
deterministic systematic and an unobservable stochastic
component [8]. Furthermore, Thurstone’s law of compara-
tive judgment calls for pairwise comparisons. Marschak
and Luce extended, formalized, and axiomatized this law
[9, 10]. In addition to the probit model (attributed to
Thurstone), McFadden used random utility theory to de-
rive the multinominal logit (MNL) model for estimating
choice probabilities; he received the Nobel Prize in Eco-
nomics for this contribution [11, 12].
Preference measurement
Choice-based preference measurement as described above
competes with two other approaches: rating (which makes
survey respondents assign numerical values to alterna-
tives), and ranking (which makes them construct a prefer-
ence ordering of alternatives). Numerous studies identify
preferences from respondents’ ratings, rankings, or
choices. While rating techniques are critically discussed, all
three approaches require basic assumptions of logic
and consistency. They differ in terms of additional as-
sumptions about preference measurability, levels of
cognitive effort, and vulnerability to biases. In particular, a
rating assumes utility to be a cardinally measured quantity
(which it is not). As shown in BWS - survey of methods
of the companion paper, ratings therefore cannot predict
choice [6].
Best-worst scaling
BWS was developed in the late 1980s as an alternative
to existing approaches. Flynn distinguishes three cases of
BWS which have in common that respondents, rather
than just identifying the best alternative, simultaneously
select the best and worst alternative from a set of three
or more attributes, attribute levels or alternatives [13–15].
One of the three variants is very similar to DCEs, making
it well anchored in economic theory.
Variants of best-worst scaling
Object case BWS
The first variant of BWS is the attribute or object case.
It is the original form of BWS as proposed by Finn and
Louviere [16]. The object case is designed to determine
the relative importance of attributes [14]. Accordingly,
attributes have no (or only one) level, and choice scenar-
ios differ merely in the particular subset of attributes
shown. Figure 1 illustrates the case of three relevant at-
tributes. Respondents are asked to identify the best and
worst or the most and least preferred attribute from the
set of scenarios [13]. The number of scenarios required
to identify a complete ranking depends on the number
of attributes. The BWS object case originally was con-
ceived as a replacement for traditional methods of meas-
urement such as ratings and Likert scales [14].
Profile case BWS
The second BWS variant is the profile case [17]. In con-
trast to the object case, the level of each attribute is
shown. Accordingly, the same attributes appear in each
scenario, while their levels change. Respondents identify
both the best (most preferred) and worst (least pre-
ferred) attribute level in each scenario presented [15]. In
Fig. 2 a possible healthcare intervention is characterized
Fig. 1 Example of an object case BWS choice scenario
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by five attributes: length of life, activities of daily living,
side effects, cost, and duration of treatment. Profile case
BWS has advantages relative to both the object case and
DCEs. Contrary to object case BWS, respondents expli-
citly value attribute levels, making choices much more
transparent and informative. Because they have to evalu-
ate only one profile scenario at a time, constructing ex-
perimental designs is easier compared to DCEs. DCEs
have to display choice sets, containing two or more
choice alternatives. Therefore profiles have to be com-
bined correctly with one or more additional profiles.
Some authors argue that profile case BWS also reduces
the cognitive burden of the elicitation task [17]. Accord-
ingly, they claim that these two advantages allow an in-
crease in the number of attributes to be valued.
Multiprofile case BWS
The third BWS variant is the multiprofile case [14, 18].
Contrary to the two previous cases, respondents repeat-
edly choose between alternatives that include all the at-
tributes, with their levels varying in a sequence of
choice sets. Thus, the multiprofile case BWS amounts
to a best-worst discrete choice experiment (BWDCE).
A BWDCE extracts more information from a choice
scenario than a conventional DCE because it asks not
only for the best (most preferred) but also the worst
(least preferred) alternative. A complete ranking of
more than three alternatives requires the exclusion of
alternatives already identified as best and worst and
asking the same question again with reference to the
reduced choice set [13].
An example choice scenario is shown in Fig. 3, taking
again a healthcare intervention as the example. Respon-
dents now need to evaluate five attribute levels to iden-
tify alternatives as best and worst, respectively. The fact
that the respondent shown considers alternative 1 as
the worst indicates that he or she does not value length
of life quite so highly but dislikes the personal cost of
treatment. Conversely, by identifying alternative 3 as
best, the same respondent indicates that he or she
would be interested in improving activities of daily liv-
ing or reducing cost, while length of life is relatively
less important (otherwise, policy 3 would have been
more preferred).
Fig. 2 Example of a profile case BWS choice scenario
Fig. 3 Example of a multiprofile case BWS choice scenario
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Conducting a BWS experiment
Study design
The first step in conducting a BWS experiment is to state
the research question and to define the decision problem,
with the objective of identifying the set of relevant attri-
butes. This calls for a comprehensive literature search in
addition to expert surveys, personal interviews, and pre-
tests (which usually involve interviews or focus groups)
[19]. Several requirements need to be met. First, the attri-
butes and attribute levels selected should be relevant to
respondents while still being under control by the relevant
decision makers. Second, they should be in a substitutive
relationship (otherwise no trade-offs are required), not
lexicographic (otherwise no trade-offs are accepted), lack
dominance (for the same reason), and be clearly defined
[20]. Finally, they need to be sufficiently realistic to ensure
that respondents take the experiment seriously.
Attributes and levels
Several methods are available for choosing attributes
that can be used in combination. Direct approaches in-
clude the elicitation technique, the repertory grid
method, as well as directly asking for attributes relative
subjective importance. All essential attributes should ap-
pear in the choice scenarios to avoid specification error
in estimating the utility function.
With the relevant attributes identified, their levels
need to be defined (at least for BWS profile and multi-
profile cases). Their ranges should represent the per-
ceived differences in respondents’ utility associated with
the most and least preferred level. However, the reverse
is not true: A respondent’s maximum difference in utility
may fall short of or exceed the spread between levels as
imposed by the experiment. Also, requiring attribute
levels to be realistic appears intuitive. Yet, the experi-
ment may call for a spreading of levels, especially in an
attribute whose (marginal) utility is to be estimated with
high precision (this is the price attribute if willingness-
to-pay values are to be calculated).
Alternatives
Defining full attribute-level descriptions is required only
for multiprofile case BWS, where respondents are asked to
evaluate alternatives. If one were to present them with all
possible combinations, they would have to deal with hun-
dreds, even thousands of combinations. For instance, four
attributes with five levels each already result in as many as
54 = 625 combinations – too many to handle for any re-
spondent. However, this number can be reduced using a
method analogous to principal-component analysis, at the
price of a certain loss of information (for more details, see
[2, 4]). In healthcare, the alternatives could represent differ-
ent health technologies, treatments, or ways of providing
care, characterized by varying attribute levels (see Fig. 2).
Experimental design
Survey design involves constructing scenarios comprising
combinations of attributes or attribute levels. As in the
case of a DCE, there are several options available for BWS.
The full-factorial design only can be used for a maximum
of three attributes with three levels each, the number of
scenarios attaining already 33 = 27. In all other cases, a
fractional factorial design is advisable. Here, the selection
of scenarios is structured to generate the maximum
amount of information. Thus scenario selection depends
critically on relationships among attributes [21]. Several
options are described in more detail below, with no one
dominating the other two in terms of all criteria [22].
Manual design
From a complete list of possible combinations, suitable
designs can be created manually by judiciously balancing
several criteria, viz. the number of scenarios involving
high and low (assumed) utility values, low correlation of
attributes (orthogonality), balanced representation, and
minimum overlap of levels [23]. If the reduced number
of choice scenarios to be presented to respondents turns
out to be still excessive, design blocks have to be created.
For example, one-half of the respondents are assigned to
one block of scenarios while the other half is assigned to
another block. Assignment of respondents to blocks
should be random to avoid selection bias.
A frequently used alternative is the Balanced Incom-
plete Block Design (BIBD) [24]. Because a BIBD is sub-
ject to the symmetry requirement, the number of
possible BIBDs is limited. For guidance concerning cre-
ation, analysis, and operationalization of manual designs,
the main reference is Cochran and Cox, who created a
multitude of ready-to-use BIBDs [25]. Ways to increase
design efficiency are described in Chrzan and Orme and
Louviere et al. [22, 26]. More recently, optimal and near-
optimal designs complementing the manual approach
have been developed [27].
Optimized design
Rather than manually developing a design, researchers
can use automated (often computerized) procedures. For
example, the software package SAS offers several search
algorithms to determine the most efficient design of a
given experiment [23]. Simple orthogonal main-effect
design plans (OMEPs) are available as well (e.g. in SPSS).
Easy to use, they have been popular in BWS.
Data analysis
The data collected in the course of a BWS experiment
can be analysed in several ways. The four most import-
ant are described in this section.
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Count analysis
Orthogonal BWS designs can be analysed using count
analysis, which is limited to examining choice frequen-
cies. Count analysis may therefore be applied across all
respondents as well as at the individual-respondent level
[14]. A best-worst score can be constructed based on
the difference Total(Best) – Total(Worst) [28].
Some authors propose taking the square root of the ratio
Total(Best)/Total(Worst), either at the level of a single attri-
bute or at the level of complete decision scenarios [15].
The square root of the ratio between best and worst
counts decreases as a function of r, the number of alterna-
tives presented in a nonlinear, degressive way. A degree of
standardization can be achieved by dividing best-worst
scores by the product of the frequency of occurrence (attri-
butes, levels, alternatives) and sample size. For more details,
see in particular Louviere as well as Crouch and Louviere
[29]. Count scores provide information about the import-
ance and hierarchy of attributes but fail to ensure compar-
ability of results across BWS studies. Specifically, no
conclusions regarding the relative economic importance of
attributes measured by marginal rates of substitution are
possible. Recall that the subjective distance between best
and worst may turn out differently because distances be-
tween best and worst are not scale-invariant (see Section
5.3 of the companion paper for details). As a consequence,
questions such as whether there are differences in trade-
offs between side effects and prolonging life between young
and old people cannot be answered.
Multinomial logit, mixed logit and rank-ordered logistic re-
gression models
One use of BWS is to determine the likelihood that an
attribute, an attribute level, or an alternative is identified
as most important or least important. This calls for dual
coding, namely best = 1 if the attribute is chosen as the
most important in the combination, and best = 0 other-
wise, as well as worst = 1 if it is cited as least important,
and worst = 0 otherwise. As a result, there are two vari-
ables to be analysed, both of which can only take on the
values zero and one. Taking into account that 0 and 1
bound a probability, the logit procedure yields propen-
sity scores reflecting the probability of an attribute being
present in a given combination.
A linear regression also produces estimates of relative im-
portance, which however may fall outside the allowable
range bounded by zero and one and hence cannot be inter-
preted as choice probabilities. Some authors neglect this,
applying weighted least squares. The weighting is necessary
because the (0,1) property of the dependent variable causes
the error term ε to have non-constant variance, violating a
requirement of ordinary least squares [30]. While logit
models are rooted in random utility theory and hence real-
world choice behaviour, linear probability models do not
bear a direct relationship with choice and decision making.
Note that logit coefficients do not reflect differences in
probability but need to be transformed for this purpose.
Also, since a regression determines the conditional ex-
pected value of the dependent variable, it measures average
preferences rather than those of an individual person [31].
By introducing interaction terms (see above), socio-
economic characteristics can be taken into account, allow-
ing for group-specific estimates. These are usually sufficient
for decision-making in health policy but may be a short-
coming in a marketing context. Details can be found in
Flynn et al., Flynn et al. as well as Wirth [30–32].
A popular MNL-based model for best-worst choice is
the maxdiff model. The maxdiff procedure calls for iden-
tifying the maximum difference in utility. As shown by
Flynn and Marley, the generalization of the MNL model
assumes that the utility associated with the choice of the
best option is the negative of the utility of associated
with the choice of the worst option [33]. Evidently, the
best-worst distance in the maxdiff formulation is
expressed in terms of cardinal utility, a problematic
property in view of microeconomic theory [17, 34]. Add-
itional weaknesses include failure to determine the rela-
tive importance of attributes [for more detail, see the
companion paper by Mühlbacher et al.].
The mixed logit (MXL) model overcomes some of the
limitations of the MNL model. MXL estimation accom-
modates unobserved taste heterogeneity by specifying
preference parameters as random variables with means
and standard deviations rather than fixed parameters.
MXL involves three main specification issues: (1) deter-
mination of the parameters that are to be modelled as ran-
dom variables; (2) choice of so-called mixing distributions
for the random coefficients; and (3) economic interpret-
ation of estimated random coefficients [35–37]. In return,
MXL can represent general substitution patterns because
it is not subject to the restrictive independence of irrele-
vant alternatives (IIA) property of MNL estimation [38].
Alternatively, rank-ordered logistic regression models
(ROLM) or „exploded logit“ models can be applied to
Best-Worst Scaling. ROLM allow modeling the partial
rankings obtained from the responses to the Best-Worst
Scaling questions. This robust analysis is a generalization
of the conditional logit model for ranked outcomes but
does not violate the assumption of the independence of
irrelevant alternatives (IIA) [39].
Latent class analysis
Latent class analysis, a form of cluster analysis, is particu-
larly useful in the event that attempts at forming homoge-
neous groups using observable socio-economic
characteristics fail [40]. For example, point estimates of
marginal WTP may be scattered within a certain age group,
suggesting hidden heterogeneity caused by differences in
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choice behavior not linked to age. MNL estimation thus
needs to be generalized in ways as to be able to infer two or
more latent groups of unknown size from observations.
Accordingly, along with the likelihood of a respondent
belonging to a certain group, latent class analysis estimates
group-specific utility functions without splitting the sam-
ple. Individual utilities associated with an alternative then
can be calculated as the group-specific estimate weighted
by the probability of the respondent belonging to this
group [41]. Since this probability depends on the assumed
number of latent groups and therefore has to be deter-
mined again and again in the course of the estimation, a
large number of observations are necessary to obtain sta-
tistically significant results. In hierarchical Bayes estima-
tion, to be described below, smaller samples are sufficient,
but at the cost of more restrictive assumptions [28].
Hierarchical bayes estimation
Hierarchical Bayes (HB) estimation increasingly is being
applied to the analysis of DCEs [38]. It fits a priori distri-
butions of the parameters to be estimated to the sample
data, using individual-specific data to derive a posteriori
distributions. Prior knowledge, such as the negative sign
of the coefficient pertaining to the price attribute, can be
incorporated in the estimation. While the multinominal
normal often is assumed for the priori distribution, the
rationale for assuming normal distributions for random
errors does not carry over to taste distributions. There is
no reason to suppose that tastes are symmetrically dis-
tributed with infinite support. For small designs with no
blocking, HB estimation can yield reliable individual
best-worst values even when the number of responses
per respondent is small. It is also efficient in the sense
that for estimating the utility of an individual respond-
ent, the choices of other respondents need not to be
taken into account [42]. MNL estimation allows deter-
mining the choice probability for a given choice sce-
nario. Applied to BWS data, it is very similar to HB
estimation of a DCE, with the only difference that BWS
additionally requires analysis of the worst choice. Since a
closed solution for deriving the posteriori distribution is
not available, simulation methods are required, which
are supported by standard statistical software [32].
Results and overview of recent BWS applications
The literature search generated a total of 53 publications
which met the inclusion criteria (see appendix for their list-
ing and key characteristics). As shown in Fig. 4, there was a
substantial increase in the number of BWS applications to
healthcare between the years 2006 and 2015, with zero an-
nual publications up to 2007 and around 15 recently.
Therefore, their absolute number is still rather small.
A crucial aspect of constructing a BWS experiment is
the variant which is used for data collection. The three
BWS variants (see Variants of best-worst scaling) differ
in the nature and in the complexity of the items being
chosen [33]. Out of the 53 BWS publications, 24 are ‘ob-
ject case’ (also called case 1) BWS, 24 are ‘profile case’
(also called case 2), and five are ‘multiprofile case’ (also
called case 3 or BWSDCE) studies, respectively. Thus,
studies of the ‘object case’ and ‘profile case’ have been
dominant in healthcare (see also appendix).
Fig. 4 Number of BWS Publications 2006–2015
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Furthermore, sample sizes vary considerably, ranging
from minimum N = 16 [43], to maximum N = 5,026 [44],
with a mean of N = 442 respondents. As to the topics
addressed by BWS papers, they fall in two main categor-
ies, value of health (derived from the valuation of health
states) and value of health care or intervention (derived
from the valuation of treatment characteristics or
changes in attribute levels).
Only eight of the 53 publications focus on the value of
health in terms of health-related quality of life: they are
usually based on patient reported outcomes. By way of
contrast, 31 publications use BWS for the evaluation of
an intervention, usually based on clinician reported out-
comes. The remaining 14 studies address policy issues,
examining societal preferences. Over time, there has
been an increase in the number of BWS applications re-
volving around patient and expert preferences (see also
Fig. 4).
Discussion: strengths and weaknesses in
application
BWS has a wide range of potential applications, ran-
ging from estimating utility functions and marginal
willingness to pay associated with specific attributes
and entire alternatives to predicting likely acceptance
of innovative healthcare products and services. While
BWS is well-established in management science and
marketing, it is much less used in health economics
and health services research, although there is an in-
creasing trend.
Latent utility scale
Flynn et al. complemented their study of patient prefer-
ences with a comparison of estimation methods, finding
the results of weighted least squares to be quite compar-
able to those of far more demanding MNL estimation
[31]. Furthermore, they claim that a traditional DCE
cannot be used to assign relative utility weights to attri-
bute levels because parameter estimates and an unob-
served scale factor are confounded. If true, this would
amount to a major deficiency because valuation of attri-
bute levels such as the difference in length of life be-
tween 3 months and 9 months plays an important role
in utility assessment and health policy. Moreover, a mar-
ginal change in levels often needs to be evaluated against
a discrete change such as the presence or absence of an
attribute. However, as argued in Section 5.2 of the com-
panion paper, the alleged unobserved scale factor may
be the consequence of a failure to identify preferences
correctly.
Accuracy of predictions
BWS, in particular Case 3, was found to merely consti-
tute a refinement of a DCE, allowing for more accurate
but not fundamentally different measurement of utility
differences. Comparing six approaches for determining
the importance of attributes Chrzan and Golovashkina
conclude that BWS improves discrimination of attributes
and prediction of actual decisions [45]. This finding re-
flects the main strength of BWS, which is the informa-
tion gain achieved by collecting additional information
from each question. In this way, preference structures
can be determined more precisely or with equal preci-
sion but smaller sample size. Moreover, through step-
wise exclusion of alternatives identified as best and
worst, BWS can yield complete rather than partial
rankings.
Cognitive burden
Decreased cognitive burden placed on respondents has
been cited as an advantage of BWS; however, the avail-
able evidence is not conclusive [46]. It seems reasonable
to assume that it is easier for respondents to identify
two extreme points than to select the most preferred al-
ternative in complex decision scenarios comprising two
or more alternatives with many attributes, or to deter-
mine a complete hierarchy of attributes [16]. However,
this argument refers to profile case BWS, which is found
to lack the important property of scale invariance (see
Sections 2.4.2 and 5.3 of the companion paper). The
same caveat applies to the claim that BWS enables iden-
tifying individual preference scales.
Endogenous censoring
BWS can be seen as partial rankings of attributes or
levels based on sequential choices, causing the first re-
sponse to have an influence on that to the second ques-
tion. While this endogenous censoring changes the value
of expected utility (EU), it does not affect actual choice.
Consider the following example. In the first round, a re-
spondent has to choose among {Worst1, F, G, Best1},
with F dominated by G. He or she calculates EU as the
weighted sum of the utilities associated with these four
outcomes, with the weights given by the (exogenous)
probabilities of their occurrence. In the second round,
the choice set is reduced to {F, G, Best1}, making the re-
spondent calculate EU over three outcomes only, with
changed probability weights. However, these weights are
now endogenous because they depend on the respon-
dent’s choice in the first round. This constitutes a viola-
tion of expected utility theory. Moreover, the second-
round EU value will generally differ from the first-round
one. Yet, given that Best1 evidently dominates G, the
final choice of ‘best’ will not be affected.
Lexicographic preferences
A BWS task simply involves identifying the most or
least important decision criteria and selecting the
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attribute, level, or alternative which is considered to
be best or worst for that attribute. BWS asks the de-
cision maker to rank the attributes (or levels) in
order of importance. For example, in choosing a spe-
cific treatment option, any increase in length of life
could be more important than any improvement in
activities of daily living or any reduction in side ef-
fects. In this case the decision maker employs a non-
compensatory heuristic that rejects trade-offs among
attributes. This lexicographic strategy involves little
effort to evaluate preference-elicitation tasks. Where
information is limited or when one attribute actually
is considerably more important than all others, non-
compensatory responses can be a valid expression of
preferences. However, with greater attention to the
preference-elicitation task, decision makers might
have accepted lower levels of the dominant attribute
in return for higher levels of other attributes. Unfortu-
nately, as in traditional DCEs, it usually is impossible
to determine whether non-compensatory responses
are a valid expression of preferences or a simplifying
heuristic designed to avoid the effort of evaluating
trade-offs.
Judgment versus choice
The extra information obtained by BWS may not be
as valuable as claimed by some authors. Asking for
the best and worst attributes provides no information
about the attractiveness of the choice scenario itself,
precluding predictions of effective use or demand by
patients and consumers. For example, respondents
who consider all options of the choice scenario as
important or unimportant have no way of expressing
this in responses to preference-elicitation questions.
One solution is to add an opt-out or no-purchase
option relative to a benchmark alternative, such as,
“Is this treatment better than your current treat-
ment?” [30].
Nevertheless, being an extension of DCEs, BWS does
have advantages over traditional methods of preference
measurement such as rating or ranking. But these ad-
vantages derive from the fact that the DCE is firmly an-
chored in economic theory, ensuring that respondents
evaluate trade-offs among advantages and disadvantages
of alternatives. Besides advantages, BWS also has disad-
vantages, which ultimately relate to the fact that add-
itional experimental information comes at a cost.
Specifically, BWS increases the time respondents need
for evaluating alternatives [40, 45], casting doubt on its
alleged cognitive simplicity [15]. Moreover, respondents
are not guided by a predetermined scale as in rating,
and they are required to make a forced decision [47].
Yet forced choices are not always unrealistic, because in
many health contexts, “no treatment” is not an
acceptable option. They can always be avoided if neces-
sary by including an opt-out or no-purchase alternative
in the study design.
Conclusions and outlook
BWS has been shown to provide results of compar-
able reliability as DCEs, regardless of design and sam-
ple size [13, 18]. Thus BWS, particularly multiprofile
case BWS, is best viewed as a refinement of the con-
ventional DCE which opens up several new opportun-
ities in health economics and health services research.
In particular, increased preference information from
each respondent facilitates identification of preference
heterogeneity among respondents through including
interaction terms in the regression equation (see Dis-
cussion: strengths and weaknesses in application of
the companion paper).
There are several open questions that should be ad-
dressed in future research. According to Flynn and
colleagues [30], there is no general basis for determin-
ing sufficient sample size for a BWS study (which is
true of DCEs as well), even though there are some
guidelines (see e.g. Johnson et al. or Yang J.-C. et al.
[48, 49]). Also, modelling the random component of
the utility function with data on best and worst
choices is an important research challenge. Another
question is whether socio-economic characteristics can
be introduced through interaction terms as in a DCE.
Best responses might depend on age, gender, and in-
come in ways different from worst responses. This is
of importance because health policy makers need to
know whether the priorities of citizens vary with their
socio-economic characteristics [14]. As an additional
complication, attribute values could depend on the
levels of other attributes, as predicted by the convexity
of the indifference curves. Such dependencies have
been little explored to date, not least because the sam-
ples were too small for accurate estimation of the cor-
responding coefficients. The additional information
generated by BWS could facilitate more complex
model specifications.
Physicians, researchers, and regulators often are poorly
informed about advantages and limitations of stated-
preference methods. Despite the increased commitment
to patient-centeredness, healthcare decision makers do
not fully realize that knowledge of the subjective relative
importance of outcomes to those affected is needed to
maximize the health benefits of available healthcare
technology and resources. Therefore, establishing stated-
preference data as an essential, valid component of the
evidence base used to assess therapeutic options should
be of high priority in health economic and health ser-
vices research.
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Table 1 BWS applications in healthcare 2006-2015
Author Title Year BWS variant Application area Sampleize
Beusterien K, Kennelly MJ, Bridges JF,
Amos K, Williams MJ, Vasavada S [50]
Use of best-worst scaling to assess pa-
tient perceptions of treatments for refrac-
tory overactive bladder.
2015 Object case Evaluation of treatment
options
N = 245
Flynn TN, Huynh E, Peters TJ, Al-Janabi
H, Clemens S, Moody A, Coast J [51]
Scoring the ICECAP- A capability
instrument. Estimation of a UK general
population tariff
2015 Profile case Evaluation of health
state measurements
N = 413
Franco MR, Howard K, Sherrington C,
Ferreira PH, Rose J, Gomes JL, Ferreira
ML [52]
Eliciting older people’s preferences for
exercise programs: a best-worst scaling
choice experiment.




Gallego G, Dew A, Lincoln M, Bundy A,
Chedid RJ, Bulkeley K, Brentnall J,
Veitch C [53]
Should I stay or should I go? Exploring
the job preferences of allied health
professionals working with people with






N = 199 Response
rate 51 %
Hashim H, Beusterien K, Bridges JFP,
Amos K, Cardozo L [54]
Patient preferences for treating refractory
overactive bladder in the UK
2015 Object case Evaluation of treatment
options
N = 139
Hollin IL, Peay HL, Bridges JF [55] Caregiver preferences for emerging
duchenne muscular dystrophy
treatments: a comparison of best-worst
scaling and conjoint analysis.
2015 Profile case Evaluation of treatment
options
N/A
Meyfroidt S, Hulscher M, De Cock D,
Van der Elst K, Joly J, Westhovens R,
Verschueren P [56]
A maximum difference scaling survey of
barriers to intensive combination
treatment strategies with glucocorticoids
in early rheumatoid arthritis.
2015 Object case Evaluation of treatment
options
N = 66
Morrison W, Womer J, Nathanson P,
Kersun L, Hester DM, Walsh C, Feudtner
C [57]
Pediatricians’ Experience with Clinical






Mühlbacher AC, Bethge, Kaczynski A,
Juhnke C [58]
Objective Criteria in the Medicinal
Therapy for Type II Diabetes: An Analysis
of the Patients’ Perspective with Analytic
Hierarchy Process and Best-Worst Scaling
2015 Profile case Evaluation of treatment
preferences
N = 388
Narurkar V, Shamban A, Sissins P,
Stonehouse A, Gallagher C [59]
Facial treatment preferences in
aesthetically aware women
2015 Object case Evaluation of aesthetic
surgeries
N = 603
O’Hara NN, Roy L, O’Hara LM, Spiegel
JM, Lynd LD, FitzGerald JM, Yassi A,
Nophale LE, Marra CA [60]
Healthcare worker preferences for active
tuberculosis case finding programs in
South Africa: a best-worst scaling choice
experiment.
2015 Profile case Evaluation of screening
interventions
N = 125 Response
rate 82 %
Peay HL, Hollin IL, Bridges JFP [61] Prioritizing Parental Worry Associated
with Duchenne Muscular Dystrophy
Using Best-Worst Scaling
2015 Object case Evaluation of disease
effects
N = 119
Ratcliffe J, Huynh E, Stevens K, Brazier J,
Sawyer M, Flynn T [62]
Nothing about us without us? A
comparison of adolescent and adult
health-state values for the child health
utility-9D using profile case Best-Worst
Scaling
2015 Profile case Evaluation of health
state values
N/A
Ross M, Bridges JF, Ng X, Wagner LD,
Frosch E, Reeves G, dosReis S [63]
A best-worst scaling experiment to
prioritize caregiver concerns about
ADHD medication for children.
2015 Object case Evaluation of a
treatment option
N = 46
Wittenberg E, Bharel M, Saada A,
Santiago E, Bridges JF, Weinreb L [64]
Measuring the Preferences of Homeless
Women for Cervical Cancer Screening
Interventions: Development of a Best-
Worst Scaling Survey.
2015 Object case Evaluation of Screening
Interventions
N/A
Yan K, Bridges JF, Augustin S, Laine L,
Garcia-Tsao G, Fraenkel L [65]
Factors impacting physicians’ decisions
to prevent variceal hemorrhage.
2015 Object case Evaluation of treatment
preferences
N = 110
Damery S, Biswas M, Billingham L,
Barton P, Al-Janabi H, Grimer R [66]
Patient preferences for clinical follow-up
after primary treatment for soft tissue






N = 132 Response
rate 47 %
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Table 1 BWS applications in healthcare 2006-2015 (Continued)
dosReis S, Ng X, Frosch E, Reeves G,
Cunningham C, Bridges JF [67]
Using Best-Worst Scaling to Measure
Caregiver Preferences for Managing their
Child’s ADHD: A Pilot Study.





Ejaz A, Spolverato G, Bridges JF, Amini
N, Kim Y, Pawlik TM [68]
Choosing a cancer surgeon: analyzing
factors in patient decision making using
a best-worst scaling methodology.
2014 Object case Evaluation of treatment
options
N = 214 Response
rate 82 %
Hauber AB, Mohamed AF, Johnson FR,
Cook M, Arrighi HM, Zhang J,
Grundman M [69]
Understanding the relative importance
of preserving functional abilities in
Alzheimer’s disease in the United States
and Germany.
2014 Object case Evaluation of
preventing treatments
N = 403 US N =
400 German
Hofstede SN, van Bodegom-Vos L,
Wentink MM, Vleggeert-Lankamp CL,
Vliet Vlieland TP, Marang-van de Mheen
PJ; DISC study group [70]
Most important factors for the
implementation of shared decision
making in sciatica care: ranking among
professionals and patients.





Peay HL, Hollin I, Fischer R, Bridges JF
[71]
A community-engaged approach to
quantifying caregiver preferences for the
benefits and risks of emerging therapies
for Duchenne muscular dystrophy.
2014 Profile case Evaluation of treatment
options
N = 119
Roy L MC, Bansback N, Marra C, Carr R,
Chilvers M, Lynd LD [72]
Evaluating preferences for long term
wheeze following RSV infection using
TTO and best-worst scaling




Torbica A, De Allegri M, Belemsaga D,
Medina-Lara A, Ridde V [73]
What criteria guide national
entrepreneurs’ policy decisions on user
fee removal for maternal health care
services? Use of a best–worst scaling
choice experiment in West Africa
2014 Object case identify criteria guiding
political decisions
N = 89
Ungar WJ, Hadioonzadeh A, Najafzadeh
M, Tsao NW, Dell S, Lynd LD [74]
Quantifying preferences for asthma
control in parents and adolescents using
best-worst scaling
2014 Object case Evaluation of a
treatment option
N = 50 parents N =
51 asthma-affected
adolescents
van Til J, Groothuis-Oudshoorn C, Lie-
ferink M, Dolan J, Goetghebeur M [75]
Does technique matter; a pilot study
exploring weighting techniques for a
multi-criteria decision support framework
2014 Object case Evaluation of societal
preferences for
reimbursement
decisions of a health
innovation
N = 60
Whitty JA, Ratcliffe J, Chen G, Scuffham
PA [76]
Australian public preferences for the
funding of new health technologies: a
comparison of discrete choice and
profile case best-worst scaling methods




Whitty JA, Walker R, Golenko X, Ratcliffe
J [77]
A think aloud study comparing the
validity and acceptability of discrete
choice and best worst scaling methods
2014 Profile case Evaluation of
preferences for
healthcare in a priority-
setting context
N = 24
Xie F, Pullenayegum E, Gaebel K, Oppe
M, Krabbe PF [78]
Eliciting preferences to the EQ-5D-5 L
health states: discrete choice experiment







Xu F, Chen G, Stevens K, Zhou H, Qi S,
Wang Z4, Hong X, Chen X, Yang H,
Wang C, Ratcliffe J [79]
Measuring and valuing health-related
quality of life among children and ado-
lescents in mainland China–a pilot study
2014 Profile case Evaluation of health-
related quality of life
N = 815
Yuan Z, Levitan B, Burton P, Poulos C,
Brett Hauber A, Berlin JA [80]
Relative importance of benefits and risks
associated with antithrombotic therapies
for acute coronary syndrome: patient
and physician perspectives.
2014 Object case Evaluation of a
treatment option
N = 206 patients N
= 273 physicians
Severin F, Schmidtke J, Mühlbacher A,
Rogowski WH [46]
Eliciting preferences for priority setting in
genetic testing: a pilot study comparing
best-worst scaling and discrete-choice
experiments
2013 Profile case Evaluation of diagnosis
intervention
N = 26
Yoo HI, Doiron D [81] The use of alternative preference
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Table 1 BWS applications in healthcare 2006-2015 (Continued)
Gallego G, Bridges JF, Flynn T, Blauvelt
BM, Niessen LW [82]
Using best-worst scaling in horizon
scanning for hepatocellular carcinoma
technologies
2012 Object case Evaluation of diagnosis
intervention
N = 120 Response
rate 37 %
Knox SA, Viney RC, Street DJ, Haas MR,
Fiebig DG, Weisberg E, Bateson D [83]
What’s good and bad about
contraceptive products? A best-worst
attribute experiment comparing the
values of women consumers and GPs
2012 Profile case Evaluation of
contraceptive products
N = 162
Marti J [18] A best–worst scaling survey of
adolescents’ level of concern for health
and non-health consequences of
smoking
2012 Object case Evaluation of effects of
smoking
N = 376
Molassiotis A, Emsley R, Ashcroft D,
Caress A, Ellis J, Wagland R, Bailey CD,
Haines J, Williams ML, Lorigan P, Smith
J, Tishelman C, Blackhall F [84]
Applying Best-Worst scaling
methodology to establish delivery
preferences of a symptom supportive
care intervention in patients with lung
cancer
2012 Profile case Evaluation of treatment
options
N = 87
Netten A, Burge P, Malley J, Potoglou
D, Towers AM, Brazier J, Flynn T, Forder
J, Wall B [85]
Outcomes of social care for adults:
developing a preference-weighted
measure.
2012 Profile case Evaluation of social
care outcome
N = 500 general




Ratcliffe J, Flynn T, Terlich F, Stevens K,
Brazier J, Sawyer M [86]
Developing adolescent-specific health
state values for economic evaluation: an
application of profile case best-worst








van der Wulp I, van den Hout WB, de
Vries M, Stiggelbout AM, van den
Akker-van Marle EM [87]
Societal preferences for standard health







Al-Janabi H, Flynn TN, Coast J [88] Estimation of a preference-based carer
experience scale




Kurkjian TJ, Kenkel JM, Sykes JM, Duffy
SC [89]
Impact of the current economy on facial
aesthetic surgery
2011 Object case Evaluation of economy
of aesthetical surgery
N = 231 surgeons
N/A for patients
Ratcliffe J, Couzner L, Flynn T, Sawyer
M, Stevens K, Brazier J, Burgess L [43]
Valuing Child Health Utility 9D health
states with a young adolescent sample: a
feasibility study to compare best-worst
scaling discrete-choice experiment,
standard gamble and time trade-off
methods
2011 Profile case Evaluation of health
state values
N = 16
Rudd MA [90] An Exploratory Analysis of Societal
Preferences for Research-Driven Quality
of Life Improvements in Canada
2011 Object case Evaluation of quality of
life
N = 1920
Simon A [91] Patient involvement and information
preferences on hospital quality: results of
an empirical analysis
2011 Object case Evaluation of patient-
oriented healthcare
information
N = 276 response
rate 71 %
van Hulst LT, Kievit W, van Bommel R,
van Riel PL, Fraenkel L [92]
Rheumatoid arthritis patients and
rheumatologists approach the decision
to escalate care differently: results of a
maximum difference scaling experiment
2011 Object case Evaluation of care N = 106 rheumato-
logists N = 213
patients
Wang T, Wong B, Huang A, Khatri P, Ng
C, Forgie M, Lanphear JH, O’Neill PJ
[93]
Factors affecting residency rank-listing: a
Maxdiff survey of graduating Canadian
medical students




Günther OH, Kürstein B, Riedel-Heller
SG, König HH [44]
The role of monetary and nonmonetary
incentives on the choice of practice
establishment: a stated preference study
of young physicians in Germany




Imaeda A, Bender D, Fraenkel L [94] What Is Most Important to Patients when
Deciding about Colorectal Screening?
2010 Object case Evaluation of screening
interventions
N = 92
Louviere JJ, Flynn TN [14] Using best-worst scaling choice
experiments to measure public
2010 Object case Evaluation of
healthcare system
reform principles
N = 204 response
rate 85 %
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